{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:38:05Z","timestamp":1791250685574,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T00:00:00Z","timestamp":1311033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10549-011-1674-0","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T16:45:44Z","timestamp":1311007544000},"page":"1009-1023","source":"Crossref","is-referenced-by-count":57,"title":["Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members"],"prefix":"10.1007","volume":"132","author":[{"given":"Mads","family":"Thomassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V. O.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge S.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Guti\u00e9rrez-Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fachal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Santamari\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane Y.","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"J\u00f8nson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Agata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tognazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tornero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Balma\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben A.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conxi","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orland","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda B.","family":"Spurdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,19]]},"reference":[{"key":"1674_CR1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/02841860802004974","volume":"47","author":"M Thomassen","year":"2008","unstructured":"Thomassen M, Hansen TV, Borg A, Lianee HT, Wikman F, Pedersen IS, Bisgaard ML, Nielsen FC, Kruse TA, Gerdes AM (2008) BRCA1 and BRCA2 mutations in Danish families with hereditary breast and\/or ovarian cancer. Acta Oncol 47:772\u2013777","journal-title":"Acta Oncol"},{"key":"1674_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O Diez","year":"2003","unstructured":"Diez O, Osorio A, Duran M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, Vega A, Campos B, Rodriguez-Lopez R, Velasco E, Chaves J, Diaz-Rubio E, Jesus CJ, Torres M, Esteban E, Cervantes A, Alonso C, San Roman JM, Gonzalez-Sarmiento R, Miner C, Carracedo A, Eugenia AM, Caldes T, Benitez J, Baiget M (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301\u2013312","journal-title":"Hum Mutat"},{"key":"1674_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.2007.13.2118","volume":"26","author":"S Malacrida","year":"2008","unstructured":"Malacrida S, Agata S, Callegaro M, Casella C, Barana D, Scaini MC, Manoukian S, Oliani C, Radice P, Barile M, Menin C, D\u2019Andrea E, Montagna M (2008) BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy. J Clin Oncol 26:26\u201331","journal-title":"J Clin Oncol"},{"key":"1674_CR4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/7.5.919","volume":"7","author":"MQ Zhang","year":"1998","unstructured":"Zhang MQ (1998) Statistical features of human exons and their flanking regions. Hum Mol Genet 7:919\u2013932","journal-title":"Hum Mol Genet"},{"key":"1674_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11:377\u2013394","journal-title":"J Comput Biol"},{"key":"1674_CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","volume":"4","author":"MG Reese","year":"1997","unstructured":"Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4:311\u2013323","journal-title":"J Comput Biol"},{"key":"1674_CR7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","volume":"29","author":"M Pertea","year":"2001","unstructured":"Pertea M, Lin X, Salzberg SL (2001) GeneSplicer: a new computational method for splice site prediction. Nucl Acids Res 29:1185\u20131190","journal-title":"Nucl Acids Res"},{"key":"1674_CR8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1073774","volume":"297","author":"WG Fairbrother","year":"2002","unstructured":"Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297:1007\u20131013","journal-title":"Science"},{"key":"1674_CR9","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucl Acids Res 31:3568\u20133571","journal-title":"Nucl Acids Res"},{"key":"1674_CR10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/humu.20901","volume":"29","author":"AB Spurdle","year":"2008","unstructured":"Spurdle AB, Couch FJ, Hogervorst FB, Radice P, Sinilnikova OM (2008) Prediction and assessment of splicing alterations: implications for clinical testing. Hum Mutat 29:1304\u20131313","journal-title":"Hum Mutat"},{"key":"1674_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/humu.20811","volume":"30","author":"MP Vreeswijk","year":"2009","unstructured":"Vreeswijk MP, Kraan JN, van der Klift HM, Vink GR, Cornelisse CJ, Wijnen JT, Bakker E, van Asperen CJ, Devilee P (2009) Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs. Hum Mutat 30:107\u2013114","journal-title":"Hum Mutat"},{"key":"1674_CR12","doi-asserted-by":"crossref","first-page":"E1484","DOI":"10.1002\/humu.21267","volume":"31","author":"LC Walker","year":"2010","unstructured":"Walker LC, Whiley PJ, Couch FJ, Farrugia DJ, Healey S, Eccles DM, Lin F, Butler SA, Goff SA, Thompson BA, Lakhani SR, Da Silva LM, Tavtigian SV, Goldgar DE, Brown MA, Spurdle AB (2010) Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity. Hum Mutat 31:E1484\u2013E1505","journal-title":"Hum Mutat"},{"key":"1674_CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/humu.9379","volume":"26","author":"AA Tesoriero","year":"2005","unstructured":"Tesoriero AA, Wong EM, Jenkins MA, Hopper JL, Brown MA, Chenevix-Trench G, Spurdle AB, Southey MC (2005) Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat 26:495","journal-title":"Hum Mutat"},{"key":"1674_CR14","doi-asserted-by":"crossref","first-page":"E1141","DOI":"10.1002\/humu.21181","volume":"31","author":"AB Spurdle","year":"2010","unstructured":"Spurdle AB, Lakhani SR, Da Silva LM, Balleine RL, Goldgar DE (2010) Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977\u20131G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance. Hum Mutat 31:E1141\u2013E1145","journal-title":"Hum Mutat"},{"key":"1674_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10689-008-9229-1","volume":"8","author":"C Santos","year":"2009","unstructured":"Santos C, Peixoto A, Rocha P, Vega A, Soares MJ, Cerveira N, Bizarro S, Pinheiro M, Pereira D, Rodrigues H, Castro F, Henrique R, Teixeira MR (2009) Haplotype and quantitative transcript analyses of Portuguese breast\/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin. Fam Cancer 8:203\u2013208","journal-title":"Fam Cancer"},{"key":"1674_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2007.056895","volume":"45","author":"C Bonnet","year":"2008","unstructured":"Bonnet C, Krieger S, Vezain M, Rousselin A, Tournier I, Martins A, Berthet P, Chevrier A, Dugast C, Layet V, Rossi A, Lidereau R, Frebourg T, Hardouin A, Tosi M (2008) Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet 45:438\u2013446","journal-title":"J Med Genet"},{"key":"1674_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535\u2013544","journal-title":"Am J Hum Genet"},{"key":"1674_CR18","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/humu.20899","volume":"29","author":"FJ Couch","year":"2008","unstructured":"Couch FJ, Rasmussen LJ, Hofstra R, Monteiro AN, Greenblatt MS, de WN (2008) Assessment of functional effects of unclassified genetic variants. Hum Mutat 29:1314\u20131326","journal-title":"Hum Mutat"},{"key":"1674_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-009-0359-4","volume":"119","author":"TV Hansen","year":"2010","unstructured":"Hansen TV, Steffensen AY, Jonson L, Andersen MK, Ejlertsen B, Nielsen FC (2010) The silent mutation nucleotide 744 G\u2192A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping. Breast Cancer Res Treat 119:547\u2013550","journal-title":"Breast Cancer Res Treat"},{"key":"1674_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2407-9-211","volume":"9","author":"L Mohammadi","year":"2009","unstructured":"Mohammadi L, Vreeswijk MP, Oldenburg R, van den Ouweland A, Oosterwijk JC, van der Hout AH, Hoogerbrugge N, Ligtenberg M, Ausems MG, van der Luijt RB, Dommering CJ, Gille JJ, Verhoef S, Hogervorst FB, van Os TA, Gomez GE, Blok MJ, Wijnen JT, Helmer Q, Devilee P, van Asperen CJ, van Houwelingen HC (2009) A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer 9:211","journal-title":"BMC Cancer"},{"key":"1674_CR21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE (2007) A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81:873\u2013883","journal-title":"Am J Hum Genet"},{"key":"1674_CR22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282\u20131291","journal-title":"Hum Mutat"},{"key":"1674_CR23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<381::AID-GCC14>3.0.CO;2-N","volume":"26","author":"M Santarosa","year":"1999","unstructured":"Santarosa M, Viel A, Boiocchi M (1999) Splice variant lacking the transactivation domain of the BRCA2 gene and mutations in the splice acceptor site of intron 2. Genes Chromosomes Cancer 26:381\u2013382","journal-title":"Genes Chromosomes Cancer"},{"key":"1674_CR24","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1200\/JCO.2007.13.4346","volume":"25","author":"O Diez","year":"2007","unstructured":"Diez O, Gutierrez-Enriquez S, Cajal T, Alonso C, Balmana J, Llort G (2007) Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast\/ovarian cancer families. J Clin Oncol 25:5035\u20135036","journal-title":"J Clin Oncol"},{"key":"1674_CR25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/sj.onc.1207191","volume":"23","author":"I Coupier","year":"2004","unstructured":"Coupier I, Baldeyron C, Rousseau A, Mosseri V, Pages-Berhouet S, Caux-Moncoutier V, Papadopoulo D, Stoppa-Lyonnet D (2004) Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations. Oncogene 23:914\u2013919","journal-title":"Oncogene"},{"key":"1674_CR26","doi-asserted-by":"crossref","unstructured":"Brandao RD, van RK, Tserpelis D, Garcia EG, Blok MJ (2011) Characterisation of unclassified variants in the BRCA1\/2 genes with a putative effect on splicing. Breast Cancer Res Treat. doi: 10.1007\/s10549-011-1599-7","DOI":"10.1007\/s10549-011-1599-7"},{"key":"1674_CR27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2350-9-58","volume":"9","author":"TV Hansen","year":"2008","unstructured":"Hansen TV, Bisgaard ML, Jonson L, Albrechtsen A, Filtenborg-Barnkob B, Eiberg H, Ejlertsen B, Nielsen FC (2008) Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC Med Genet 9:58","journal-title":"BMC Med Genet"},{"key":"1674_CR28","first-page":"1372","volume":"58","author":"M Nordling","year":"1998","unstructured":"Nordling M, Karlsson P, Wahlstrom J, Engwall Y, Wallgren A, Martinsson T (1998) A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast\/ovarian cancer family. Cancer Res 58:1372\u20131375","journal-title":"Cancer Res"},{"key":"1674_CR29","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-09-2564","volume":"16","author":"DJ Sanz","year":"2010","unstructured":"Sanz DJ, Acedo A, Infante M, Duran M, Perez-Cabornero L, Esteban-Cardenosa E, Lastra E, Pagani F, Miner C, Velasco EA (2010) A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast\/ovarian cancer patients. Clin Cancer Res 16:1957\u20131967","journal-title":"Clin Cancer Res"},{"key":"1674_CR30","unstructured":"Peixoto A, Santos C, Pinheiro M, Pinto P, Soares MJ, Rocha P, Gusmao L, Amorim A, van der Hout A, Gerdes AM, Thomassen M, Kruse TA, Cruger D, Sunde L, Bignon YJ, Uhrhammer N, Cornil L, Rouleau E, Lidereau R, Yannoukakos D, Pertesi M, Narod S, Royer R, Costa MM, Lazaro C, Feliubadalo L, Grana B, Blanco I, de la Hoya M, Caldes T, Maillet P, Benais-Pont G, Pardo B, Laitman Y, Friedman E, Velasco EA, Duran M, Miramar MD, Valle AR, Calvo MT, Vega A, Blanco A, Diez O, Gutierrez-Enriquez S, Balmana J, Ramon YC, Alonso C, Baiget M, Foulkes W, Tischkowitz M, Kyle R, Sabbaghian N, Ashton-Prolla P, Ewald IP, Rajkumar T, Mota-Vieira L, Giannini G, Gulino A, Achatz MI, Carraro DM, de Paillerets BB, Remenieras A, Benson C, Casadei S, King MC, Teugels E, Teixeira MR (2010) International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation. Breast Cancer Res Treat 127(3):671\u2013679"},{"key":"1674_CR31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","volume":"25","author":"PM Machado","year":"2007","unstructured":"Machado PM, Brandao RD, Cavaco BM, Eugenio J, Bento S, Nave M, Rodrigues P, Fernandes A, Vaz F (2007) Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol 25:2027\u20132034","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1674-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1674-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1674-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T23:04:45Z","timestamp":1560380685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1674-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1674-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,19]]}}}